Previous 10 | Next 10 |
2024-05-03 12:29:38 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Amgen stock rallies 13% on GLP-1 weight-loss drug update ...
Stocks jumped sharply Friday after a softer-than-expected April jobs report boosted hopes that the Federal Reserve could start cutting interest rates soon. The Dow Jones Industrials popped 524,51 points, or 1.4%, to begin Friday at 38,750.17. The S&P 500 galloped 62.12 points, or 1.2%...
Amgen Inc. (NASDAQ: AMGN) is one of today's top gainers. The company's shares have moved 12.15% on the day to $312.21. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, ...
2024-05-03 10:28:54 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Biggest stock movers today: WOW, AAPL, SQ, and more Amge...
2024-05-03 06:15:04 ET Barclays analyst issues EQUAL-WEIGHT recommendation for AMGN on May 3, 2024 04:38AM ET. The previous analyst recommendation was Underweight. AMGN was trading at $278.39 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-03 05:14:40 ET More on related stocks: Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Apple Inc. (AAPL) Q2 2024 Earnings Call Transcript Cloudflare, Inc. (NET) Q1 2024 Earnings Call Transcript Apple in charts: iPhone revenue slumps Y/Y; services ...
2024-05-02 21:12:05 ET Amgen, Inc. (AMGN) Q1 2024 Earnings Conference Call May 02, 2024, 16:30 ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President James Bradner - EVP, Research and Development & Chief Scientific Offic...
2024-05-02 17:40:21 ET More on Amgen Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Amgen Non-GAAP EPS of $3.96 beats by $0.05, revenue of $7.45B in-line ...
2024-05-02 16:17:14 ET More on Arrowhead Pharmaceuticals Arrowhead: RNAi Specialist Struggling To Show A Strong Hand (Rating Downgrade) Arrowhead Pharmaceuticals, Inc. (ARWR) Q1 2024 Earnings Call Transcript Arrowhead Pharmaceuticals jumps amid takeover speculation ...
2024-05-02 16:16:09 ET More on Amgen Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Amgen: The Giant With An Impressive Pipeline Amgen Q1 Earnings Preview: Obesity treatment updates to be the focus th...
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...